PHOX2B, a transcription factor and a specific and sensitive bio-marker for MRD in neuroblastoma patients [11, 12], is highly expressed in micro-metastatic neuroblastoma cells (MicroNB), but not, or significantly less in macro-metastatic cells (MacroNB). Here, PHOX2B is linked to neuroblastoma.